Efficacy in biologic-naive and biologic-experienced patients for ixekizumab versus guselkumab in moderate-to-severe psoriasis: head-to-head results from IXORA-R
AUSTRALASIAN JOURNAL OF DERMATOLOGY(2022)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要